Home » Topics » BioWorld Science

BioWorld Science
RSS

OGS achieves solid progress during first half of 2001

Oct. 19, 2001

Angiogene secures further R&D funding

Oct. 19, 2001

Baxter acquires epoetin omega for treating anemia

Oct. 19, 2001

Patent coverage gained for Gliatech's antiproperdin antibody therapies

Oct. 18, 2001

Ortho-McNeil patents new series of neuropeptide Y5 receptor ligands

Oct. 18, 2001

Hydroxamic acid-based inhibitors of sCD23 formation and TNF processing

Oct. 18, 2001

FDA clears use of Allergan's Tazorac cream for treatment of acne

Oct. 18, 2001

Intranasal morphine tested for relief of breakthrough pain in cancer patients

Oct. 18, 2001

Preparation and use of A2A receptor agonists in heart imaging

Oct. 18, 2001

Cholinergic function modulators claimed for use in nicotine addiction and other disorders by Pfizer

Oct. 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...